Sergio Traversa, Director at Actinium Pharmaceuticals, holds 75.49K shares in Relmada Therapeutics (Ticker: RLMD), holds 0.00 shares in Actinium Pharmaceuticals (Ticker: ATNM).

See the Hottest Stocks Based on Insider Trading >

Sergio Traversa
Actinium Pharmaceuticals (ATNM)
Director

Not Ranked

Sergio Traversa has not reported sufficient informative transactions and therefore cannot be ranked.

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

RLMD

0.00%

ATNM

A breakdown of Sergio Traversa's holdings

See the Top Stocks by Insiders

Insider Roles

Relmada Therapeutics
(RLMD)

CEO, Director

Actinium Pharmaceuticals
(ATNM)

Director

Roles that Sergio Traversa holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Actinium Pharmaceuticals
(ATNM)

Rating:Informative Buy

Date:Apr 18, 2016 - Apr 18, 2017

Return:-22.60%

The most profitable trade made by Sergio Traversa

See the Latest Stocks Traded by Insiders

Sergio Traversa's Trading History

ATNM

Actinium Pharmaceuticals

Apr 18, 2016

Director

Informative Buy

6.06K

$0.00

RLMD

Relmada Therapeutics

Aug 19, 2020

CEO, Director

Uninformative Sell

162.01K

$2.72M

List of latest transactions for each holding click on a transaction to see Sergio Traversa's performance on stock

See All Insider Trading from Today

Sergio Traversa insider profile FAQ

What is the percentage of profitable transactions made by Sergio Traversa?

The percentage of profitable transactions made by Sergio Traversa is ―.

What is the average return per transaction made by Sergio Traversa?

The average return per transaction made by Sergio Traversa is ―.

What stocks does Sergio Traversa hold?

Sergio Traversa holds: ATNM, RLMD stocks.

What was Sergio Traversa’s latest transaction?

Sergio Traversa latest transaction was an Uninformative Sell of $162.01K.

What was Sergio Traversa's most profitable transaction?

Sergio Traversa’s most profitable transaction was an Informative Buy of ATNM stock on April 18, 2016. The return on the trade was -22.60%.

What is Sergio Traversa's role in Actinium Pharmaceuticals?

Sergio Traversa's role in Actinium Pharmaceuticals is Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Sergio Traversa Insider Profile

Sergio Traversa Actinium Pharmaceuticals (ATNM)Director